These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26110221)

  • 61. Opioid substitution treatment in New Zealand: a 40 year perspective.
    Deering D; Sellman JD; Adamson S
    N Z Med J; 2014 Jul; 127(1397):57-66. PubMed ID: 24997702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients.
    Ledgerwood DM; Lister JJ; LaLiberte B; Lundahl LH; Greenwald MK
    Addict Behav; 2019 Mar; 90():191-195. PubMed ID: 30412910
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adapting methadone inductions to the fentanyl era.
    Buresh M; Nahvi S; Steiger S; Weinstein ZM
    J Subst Abuse Treat; 2022 Oct; 141():108832. PubMed ID: 35870437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urine toxicology screen negative for Methadone metabolite but positive for Methadone in a patient on Methadone maintenance therapy (MMT).
    Ravishankar DA; Calhoun E; Sethi R; Din A
    Asian J Psychiatr; 2020 Apr; 50():101969. PubMed ID: 32109808
    [No Abstract]   [Full Text] [Related]  

  • 65. Attitudes and practices regarding the use of methadone in US state and federal prisons.
    Rich JD; Boutwell AE; Shield DC; Key RG; McKenzie M; Clarke JG; Friedmann PD
    J Urban Health; 2005 Sep; 82(3):411-9. PubMed ID: 15917502
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of a 'microecologic technique' to study crime incidents around methadone maintenance treatment centers - a response: The journal publishes both invited and unsolicited letters.
    Gupta R; Sarkar S; Balhara YP
    Addiction; 2012 Oct; 107(10):1883. PubMed ID: 22831569
    [No Abstract]   [Full Text] [Related]  

  • 67. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
    Lee HY; Li JH; Wu LT; Wu JS; Yen CF; Tang HP
    Subst Abuse Treat Prev Policy; 2012 Mar; 7():11. PubMed ID: 22429858
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders.
    Winetsky D; Weinrieb RM; Perrone J
    J Hosp Med; 2018 Jan; 13(1):62-64. PubMed ID: 29073311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
    Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
    Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heroin-assisted treatment for opioid dependence: randomised controlled trial.
    Haasen C; Verthein U; Degkwitz P; Berger J; Krausz M; Naber D
    Br J Psychiatry; 2007 Jul; 191():55-62. PubMed ID: 17602126
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Primary Care Physicians' Views about Prescribing Methadone to Treat Opioid Use Disorder.
    Livingston JD; Adams E; Jordan M; MacMillan Z; Hering R
    Subst Use Misuse; 2018 Jan; 53(2):344-353. PubMed ID: 28853970
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Harm reduction program use, psychopathology and medical severity in patients with methadone maintenance treatment.
    Martínez-Luna NG; Rodríguez-Cintas L; Esojo A; Palma-Álvarez RF; Robles-Martínez M; Grau-López L; Perea M; Roncero C
    Adicciones; 2018 Jan; 30(3):197-207. PubMed ID: 29353292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The feasibility and acceptability of groups for pain management in methadone maintenance treatment.
    Barry DT; Savant JD; Beitel M; Cutter CJ; Schottenfeld RS; Kerns RD; Moore BA; Oberleitner L; Joy MT; Keneally N; Liong C; Carroll KM
    J Addict Med; 2014; 8(5):338-44. PubMed ID: 25100310
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of methadone treatment retention from a multi-site study: a survival analysis.
    Kelly SM; O'Grady KE; Mitchell SG; Brown BS; Schwartz RP
    Drug Alcohol Depend; 2011 Sep; 117(2-3):170-5. PubMed ID: 21310552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients.
    Peles E; Schreiber S; Domany Y; Sason A; Tene O; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):620-8. PubMed ID: 24666249
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methadone for the treatment of Prescription Opioids Dependence. A retrospective chart review.
    Barrio P; Ezzeldin M; Bruguera P; Pérez A; Mansilla S; Fàbrega M; Lligoña A; Mondón S; Balcells M
    Adicciones; 2016 Jun; 29(1):55-60. PubMed ID: 27391853
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
    Ling W
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):394-400. PubMed ID: 27008037
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methadone complications amongst opioid-dependent patients in Malaysia: A case series.
    George P; Vicknasingam B; Thurairajasingam S; Ramasamy P; Mohd Yusof H; Yasin MABM; Shah ZUBS
    Drug Alcohol Rev; 2018 Jan; 37(1):147-151. PubMed ID: 27859761
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methadone treatment centers and crime: the journal publishes both invited and unsolicited letters.
    Mooney G
    Addiction; 2012 Nov; 107(11):2051-2; author reply 2052-3. PubMed ID: 23039754
    [No Abstract]   [Full Text] [Related]  

  • 80. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.
    Nosyk B; Li L; Evans E; Urada D; Huang D; Wood E; Rawson R; Hser YI
    Drug Alcohol Depend; 2014 Oct; 143():149-57. PubMed ID: 25110333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.